GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for an IPO to fund development of vaccines that could compete with companies including GSK, Merck & Co. and Pfizer.